(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;sulfuric acid;hydrate

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: (4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;sulfuric acid;hydrate
• 化学式: C18H23NO9S
• 分子量: 429.4
• InChiKey: IGUAHHYADOOLFE-PCHTVJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.65
• 重原子数：
  29
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  143
• 氢给体数：
  4
• 氢受体数：
  10

文献信息

• SYNTHESIS OF OXYCODONE HYDROCHLORIDE
  申请人：Cody Laboratories, Inc.

  公开号：US20150166553A1

  公开（公告）日：2015-06-18

  Synthetic methods are provided for preparation of oxycodone and salts thereof with an improved impurity profile. Thebaine is converted to 14-hydroxycodeinone sulfate intermediate to minimize a 7,8-dihydro-8,14-dihydroxycodeinone impurity. Efficient methods for conversion of oxycodone base to oxycodone hydrochloride are provided to minimize 14-hydroxycodeinone impurity in the final product.

  提供了一种合成方法，用于制备氧可酮及其盐，具有改进的杂质特性。 将橙皮碱转化为14-羟基可待因酮硫酸盐中间体，以减少7,8-二氢-8,14-二羟基可待因酮的杂质。 提供了将氧可酮碱转化为氧可酮盐酸盐的高效方法，以减少最终产品中的14-羟基可待因酮杂质。
• CONVERSION OF OXYCODONE BASE TO OXYCODONE HYDROCHLORIDE
  申请人：Cody Laboratories, Inc.

  公开号：US20150166552A1

  公开（公告）日：2015-06-18

  Synthetic methods are provided for preparation of oxycodone and salts thereof with an improved impurity profile. Thebaine is converted to 14-hydroxycodeinone sulfate intermediate to minimize a 7,8-dihydro-8,14-dihydroxycodeinone impurity. Efficient methods for conversion of oxycodone base to oxycodone hydrochloride are provided to minimize 14-hydroxycodeinone impurity in the final product.

  提供了合成方法，用于制备盐酸氧可酮及其改进的杂质谱。将蒂巴因转化为14-羟基可待因酮硫酸盐中间体，以最小化7,8-二氢-8,14-二羟基可待因酮杂质。提供了将氧可酮碱转化为盐酸氧可酮的高效方法，以最小化最终产品中的14-羟基可待因酮杂质。
• [EN] PROCESS FOR IMPROVED OPIOID SYNTHESIS<br/>[FR] PROCÉDÉ POUR AMÉLIORER LA SYNTHÈSE D'OPIOÏDES
  申请人：RHODES TECHNOLOGIES

  公开号：WO2014013311A1

  公开（公告）日：2014-01-23

  Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxycodone base and/or an oxycodone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.

  用于制备阿片类药物的起始物或中间物的化合物和组合物，例如，羟考酮基和/或羟考酮盐；制备这些化合物和组合物的过程；这些化合物和组合物在制备活性药物成分和制药剂量形式中的用途；以及这些活性药物成分和制药剂量形式在治疗医疗状况中的用途。
• [EN] PROCESS FOR IMPROVED OXYCODONE SYNTHESIS<br/>[FR] PROCÉDÉ POUR UNE MEILLEURE SYNTHÈSE DE L'OXYCODONE
  申请人：RHODES TECHNOLOGIES

  公开号：WO2015107471A1

  公开（公告）日：2015-07-23

  Processes for preparing oxycodone are provided. Said processes encompass a step which is a hydrogenation of an 14-hydroxycodeinone salt in the presence of trifluoroacetic acid and/or a glycol.

  提供了制备羟考酮的过程。所述过程包括在三氟乙酸和/或乙二醇存在下对14-羟基可待因盐进行氢化的步骤。
• PROCESS FOR IMPROVED OXYCODONE SYNTHESIS
  申请人：RHODES TECHNOLOGIES

  公开号：US20170022210A1

  公开（公告）日：2017-01-26

  Processes for preparing oxycodone are provided. Said processes encompass a step which is a hydrogenation of an 14-hydroxycodeinone salt in the presence of trifluoroacetic acid and/or a glycol.

  提供了制备羟考酮的工艺。所述工艺包括在三氟乙酸和/或乙二醇存在下对14-羟基可待因酮盐进行氢化的步骤。